Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Bortezomib-Based Induction, Augmented Conditioning with Busulfan and Melphalan + ASCT and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma: Long-Term Results of the National Canadian Mcrn-001 Study

Donna E Reece, MD, Giovanni Piza Rodriguez, MD, Mariela A Pantoja, PhD MSc, Darrell J White, MD, Christopher P Venner, MD, Julie Stakiw, MD, Michael Sebag, MD PhD, Terrance Comeau, MD, Kevin Song, MD, Jean Roy, MD, Martha L Louzada, MDMSc, Arleigh McCurdy, MD, Vishal Kukreti, MD, Suzanne Trudel, MD, Anca Prica, MD, Rodger E Tiedemann, MBChB, PhD, Harminder K Paul, MSc, Christine I Chen, MD

Blood (2019) 134 (Supplement_1): 4570.

https://doi.org/10.1182/blood-2019-129357

Published: 2019

Journal Articles

Lenalidomide and Rituximab Maintenance Therapy after Front-Line Induction Chemoimmunotherapy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Julie E Chang, MD, Vaishalee P. Kenkre, MD, Christopher D. Fletcher, MD, Aric C. Hall, MD, Natalie Scott Callander, MD, Kyungmann Kim, PhD, Grace Yi Chen, Kaitlin Chambers

Blood (2019) 134 (Supplement_1): 5470.

https://doi.org/10.1182/blood-2019-124489

Published: 2019

Journal Articles

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

K. Scott Baker, Wendy M. Leisenring, Pamela J. Goodman, Ralph P. Ermoian, Mary E. Flowers, G. Schoch, Rainer Storb, Brenda M. Sandmaier, H. Joachim Deeg

Blood (2019) 133 (26): 2790–2799.

https://doi.org/10.1182/blood.2018874115

Published: 2019

Includes: Supplemental data

Journal Articles

CD4+ T-Cell Lymphopenia in Frequent Platelet Donors Who Have Ceased Platelet Donation for at Least 1 Year

Mahboubeh Rahmani, MD, Brooke M Fortin, BA, BS, Nancy Berliner, MD, Nicolas C Issa, MD, Donna S Neuberg, ScD, Richard M Kaufman, MD, John M Gansner, MD PhD

Blood (2018) 132 (Supplement 1): 2550.

https://doi.org/10.1182/blood-2018-99-118967

Published: 2018

Journal Articles

Risk and Outcomes of Second Malignant Neoplasms in Chronic Myeloid Leukemia Survivors

Omer Jamy, Rehan Sarmad, MD MBBS, Luciano J. Costa, MD PhD

Blood (2017) 130 (Supplement 1): 350.

https://doi.org/10.1182/blood.V130.Suppl_1.350.350

Published: 2017

Journal Articles

Factors Associated with Non-Melanoma Skin Cancer (NMSC) Among Chronic Lymphocytic Leukemia (CLL) Patients

Geffen Kleinstern, PhD, Abdul Rishi, Sara J Achenbach, Kari G Chaffee, MS, Neil E. Kay, MD, Tait D Shanafelt, MD, Jacob Inda, Aaron Norman, Timothy G. Call, MD, Christian L Baum, MD, James R. Cerhan, MD PhD, Susan L Slager, PhD

Blood (2017) 130 (Supplement 1): 2158.

https://doi.org/10.1182/blood.V130.Suppl_1.2158.2158

Published: 2017

Journal Articles

Skin Cancers Among Chronic Lymphocytic Leukemia (CLL) Patients - the Effect of UV Radiation and CLL Clinical Characteristics

Geffen Kleinstern, PhD, Abdul Rishi, MBBS, Sara J Achenbach, Kari Rabe Chaffee, MS, Neil E. Kay, MD, Tait D. Shanafelt, MD, Aaron Norman, MPH, Celine M. Vachon, PhD, Timothy G. Call, MD, Christian L. Baum, MD, James R Cerhan, MD PhD, Susan L. Slager, PhD

Blood (2016) 128 (22): 4772.

https://doi.org/10.1182/blood.V128.22.4772.4772

Published: 2016

Journal Articles

Unique Characteristics of Classical Hodgkin Lymphoma in Patients with Cutaneous T-Cell Lymphoma

Lauren E. Strelec, BA, Erin Haley, MD, Ellen J. Kim, MD, Alain H. Rook, MD, Nirav N. Shah, MD, Anthony R. Mato, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD

Blood (2015) 126 (23): 5003.

https://doi.org/10.1182/blood.V126.23.5003.5003

Published: 2015

Journal Articles

Nano-Formulated Hydroxyurea Enhances Drug Delivery in K562 Cells

Omar Mohtar, BS, Jean Bosco Tagne, PhD, Elizabeth S Klings, MD

Blood (2015) 126 (23): 4576.

https://doi.org/10.1182/blood.V126.23.4576.4576

Published: 2015

Journal Articles

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)

Martha L Louzada, BSc, MD MSc, Michael J. Kovacs, MD FRCPC, Fatimah Al-ani, MD, Lenicio Siqueira, Alejandro Lazo-Langner, MD MSc

Blood (2014) 124 (21): 4245.

https://doi.org/10.1182/blood.V124.21.4245.4245

Published: 2014

Journal Articles

Assessment of Risk of Thromboprophylaxis Failure in Hospitalized Patients with Cancer (Artic Study)

Martha L Louzada, BSc, MD MSc, Michael J. Kovacs, MD, FAtimah Al-Ani, MD, Alejandro Lazo-Langner, MD MSc, Lenicio Siqueira

Blood (2014) 124 (21): 588.

https://doi.org/10.1182/blood.V124.21.588.588

Published: 2014

Journal Articles

Bone Marrow Endothelial Cells Protect Acute Myeloid Leukemia From Chemotherapy By Direct Contact: The BCAM/Laminin/VLA5 Axis As a Potential Therapeutic Target

Leylah Drusbosky, BS, Amy Meacham, MS, Elizabeth Wise, BS, Edward W Scott, PhD, Christopher R Cogle, MD

Blood (2013) 122 (21): 2546.

https://doi.org/10.1182/blood.V122.21.2546.2546

Published: 2013

Journal Articles

A Phase II Trial Of Bortezomib-Rituximab Followed By Autologous Stem Cell Harvest (SCH) and Cladribine-Cyclophosphamide-Rituximab (2CdA-Cy-Rit) Consolidation As Primary Therapy Of Waldenström's Macroglobulinemia (WM)

Sheeba K. Thomas, M.D., Tamara M Haygood, M.D., Muzaffar H. Qazilbash, MD, A. Georgina Melendez, M.D., Roxana Galvis, Kay B Delasalle, B.S., Lei Feng, M.S., Tiffany A. Richards, M.S., Felipe Samaniego, M.D., M.P.H, Luhua Wang, M.D., Jatin J. Shah, M.D., Robert Z. Orlowski, M.D., Ph.D., Donna M. Weber, M.D.

Blood (2013) 122 (21): 4396.

https://doi.org/10.1182/blood.V122.21.4396.4396

Published: 2013

Journal Articles

Cyclophosphamide Maintenance Therapy Is a Safe and Effective Alternative In Multiple Myeloma Patients Who Undergo Autologous Stem Cell Transplantation

Michael T. Byrne, DO, Jan S Moreb, MD

Blood (2013) 122 (21): 5373.

https://doi.org/10.1182/blood.V122.21.5373.5373

Published: 2013

Journal Articles

Influence Of Active Cancer On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II

Sam Schulman, MD, PhD, Henry Eriksson, MD, PhD, Samuel Z Goldhaber, MD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Martin Feuring, MD, Nuala Peter, BSc (Hons), Jeffrey Friedman, MD

Blood (2013) 122 (21): 582.

https://doi.org/10.1182/blood.V122.21.582.582

Published: 2013

Journal Articles

A-Kinase Anchoring Proteins Mediate Healthy and Sickle Red Blood Cell Adhesion To Endothelial Laminin-5

Jamie L. Maciaszek, MS, Biree Andemariam, MD, George Lykotrafitis, PhD

Blood (2013) 122 (21): 968.

https://doi.org/10.1182/blood.V122.21.968.968

Published: 2013

Journal Articles

Histological Assessment of Cutaneous Acute Graft-Versus-Host Disease in a Preclinical Swine Model of Hematopoietic Cell Transplantation and Vascularized Skin Flap Tolerance

George F. Murphy, MD, Raimon Duran-Struuck, DVM, PhD, Evan A. Farkash, MD, PhD, Mihail Climov, MD, David A. Leonard, MD, Curtis L. Cetrulo, Jr., MD, Thomas R. Spitzer, MD, David H. Sachs, MD, Christene A. Huang, PhD

Blood (2012) 120 (21): 1894.

https://doi.org/10.1182/blood.V120.21.1894.1894

Published: 2012

Journal Articles

Proangiogenic Effects of Plasma From Sickle Cell Disease Patients and Antiangiogenic Effects of Hydroxyurea: Evaluation of Invasion and Proliferation of Human Endothelial Cells and Effects of Hydroxyurea in a Mouse Matrigel Plug Neovascularization Assay

Fláavia Cristine Mascia Lopes, M.Sc., Ph.D., Raquel Costa, Sara T Olalla Saad, MD, PhD, Raquel Soares, Fernando Ferreira Costa, MD, PhD, Nicola Conran, Ph.D.

Blood (2012) 120 (21): 377.

https://doi.org/10.1182/blood.V120.21.377.377

Published: 2012

Journal Articles

Melanoma and Non-Melanoma Skin Cancer in Patients with Chronic Lymphocytic Leukemia.

Timothy G Call, MD, Kari G Rabe, MS, Brewer D Jerry, M.D., Neil E. Kay, MD, Clive S. Zent, MD, Susan M Schwager, Deborah A Bowen, FNP, Jose F Leis, MD, Han Tun, MD, Svetomir N Markovic, MD, PhD, Susan L Slager, PhD, Tait D. Shanafelt, M.D.

Blood (2009) 114 (22): 1268.

https://doi.org/10.1182/blood.V114.22.1268.1268

Published: 2009

Journal Articles

Treatment with Fludarabine and Rituximab Produces Extended Overall Survival (OS) and Progression-Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) without Increased Risk of Second Malignancy: Long-Term Follow up of CALGB Study 9712.

Jennifer A Woyach, MD, Amy S Ruppert, Nyla A. Heerema, PhD, Bercedis Peterson, Ph.D, John G. Gribben, MD, DSc, Vicki A. Morrison, MD, Kanti R Rai, MD, Richard A. Larson, MD, John C. Byrd, MD

Blood (2009) 114 (22): 539.

https://doi.org/10.1182/blood.V114.22.539.539

Published: 2009

NARROW

Bortezomib-Based Induction, Augmented Conditioning with Busulfan and Melphalan + ASCT and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma: Long-Term Results of the National Canadian Mcrn-001 Study

Lenalidomide and Rituximab Maintenance Therapy after Front-Line Induction Chemoimmunotherapy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

CD4+ T-Cell Lymphopenia in Frequent Platelet Donors Who Have Ceased Platelet Donation for at Least 1 Year

Risk and Outcomes of Second Malignant Neoplasms in Chronic Myeloid Leukemia Survivors

Factors Associated with Non-Melanoma Skin Cancer (NMSC) Among Chronic Lymphocytic Leukemia (CLL) Patients

Skin Cancers Among Chronic Lymphocytic Leukemia (CLL) Patients - the Effect of UV Radiation and CLL Clinical Characteristics

Unique Characteristics of Classical Hodgkin Lymphoma in Patients with Cutaneous T-Cell Lymphoma

Nano-Formulated Hydroxyurea Enhances Drug Delivery in K562 Cells

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)

Assessment of Risk of Thromboprophylaxis Failure in Hospitalized Patients with Cancer (Artic Study)

Bone Marrow Endothelial Cells Protect Acute Myeloid Leukemia From Chemotherapy By Direct Contact: The BCAM/Laminin/VLA5 Axis As a Potential Therapeutic Target

A Phase II Trial Of Bortezomib-Rituximab Followed By Autologous Stem Cell Harvest (SCH) and Cladribine-Cyclophosphamide-Rituximab (2CdA-Cy-Rit) Consolidation As Primary Therapy Of Waldenström's Macroglobulinemia (WM)

Cyclophosphamide Maintenance Therapy Is a Safe and Effective Alternative In Multiple Myeloma Patients Who Undergo Autologous Stem Cell Transplantation

Influence Of Active Cancer On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II

A-Kinase Anchoring Proteins Mediate Healthy and Sickle Red Blood Cell Adhesion To Endothelial Laminin-5

Histological Assessment of Cutaneous Acute Graft-Versus-Host Disease in a Preclinical Swine Model of Hematopoietic Cell Transplantation and Vascularized Skin Flap Tolerance

Proangiogenic Effects of Plasma From Sickle Cell Disease Patients and Antiangiogenic Effects of Hydroxyurea: Evaluation of Invasion and Proliferation of Human Endothelial Cells and Effects of Hydroxyurea in a Mouse Matrigel Plug Neovascularization Assay

Melanoma and Non-Melanoma Skin Cancer in Patients with Chronic Lymphocytic Leukemia.

Treatment with Fludarabine and Rituximab Produces Extended Overall Survival (OS) and Progression-Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) without Increased Risk of Second Malignancy: Long-Term Follow up of CALGB Study 9712.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only